| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |